Most distributors sell other people's products. Covexall is the exception in ASP's catalog: an in-house brand, born inside the same veteran-owned family of companies that runs ASP itself, and built to answer the question the pandemic asked of every sanitizer on the market — what happens after the alcohol evaporates?
Where it came from
Covexall was developed under Impact Diversity Solutions, the CVE-certified, service-disabled-veteran-owned company founded by Charles Brown, who also leads American Sanitary Products, together with co-founder Tim Johnson. The mission, documented in the company's 2022 white paper, was specific: deliver clinically proven protection for front-line workers and essential personnel that keeps working between applications — not just at the moment of use.
What makes it different
Covexall is a water-based, alcohol-free hand sanitizer built on copper-infused magnesium hydroxide microplatelet technology with benzalkonium chloride. It kills 99.9 percent of pathogens on contact and, in independent laboratory testing including studies at Arizona State University's Biodesign Institute, showed continued antimicrobial activity up to four hours after application. Kill-rate studies showed complete kill across eleven bacterial species at 60 seconds — including complete kill of C. difficile cultures and spores. And because it is water-based, it moisturizes rather than cracks skin, is painless on cuts, and is non-flammable.
Built for institutions
The product line runs from one-ounce personal pumps and four-ounce bottles through gallons, five-gallon pails, and bulk totes, with dispenser bladders for wall units — the packaging spread a facility program actually needs. It is available today through the ASP CompCare store, and by quote for contract and bulk orders.
Covexall is a topical hand sanitizer for external use only. Performance figures referenced in this article are drawn from the 2022 Covexall white paper and the independent laboratory studies cited in it, including testing conducted at Arizona State University's Biodesign Institute. Continued antimicrobial activity lasts up to four hours after application.
